Pfizer Correlations

Stocks . USA . 
Stock . Pfizer Inc
PFE Stock  USD 40.38  0.13  0.32%   
The correlation of Pfizer is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Pfizer moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Pfizer Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Check out Your Equity Center. For information on how to trade Pfizer Stock refer to our How to Trade Pfizer Stock guide.
  
The ability to find closely correlated positions to Pfizer could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Pfizer when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Pfizer - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Pfizer Inc to buy it.

Moving together with Pfizer

+0.67NVAXNovavax Fiscal Quarter End 31st of March 2023 PairCorr
+0.97JNJJohnson Johnson Fiscal Quarter End 31st of March 2023 PairCorr
+0.91PDSBPDS Biotechnology Corp Financial Report 10th of May 2023 PairCorr
+0.89PRPHProPhase Labs Financial Report 12th of May 2023 PairCorr
+0.74HOTHHoth TherapeuticsPairCorr
+0.79ACRXAcelRx Pharmaceuticals Financial Report 15th of May 2023 PairCorr
+0.87AMGNAmgen Inc Fiscal Quarter End 31st of March 2023 PairCorr
+0.87SMMTSummit Therapeutics PLC Fiscal Quarter End 31st of March 2023 PairCorr

Moving against Pfizer

-0.83TIGTrean Insurance GroupInc Fiscal Quarter End 31st of March 2023 PairCorr
-0.79SPPISpectrum Pharmaceuticals Fiscal Quarter End 31st of March 2023 PairCorr
-0.75ARDXArdelyx Fiscal Quarter End 31st of March 2023 PairCorr
-0.68REGNRegeneron Pharmaceuticals Fiscal Quarter End 31st of March 2023 PairCorr
-0.61NLTXNeoleukin Therapeutics Fiscal Quarter End 31st of March 2023 PairCorr

Related Correlations

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

The Correlation Coefficient is a useful tool to identify correlated or non-correlated securities, which is essential in developing a diversified portfolio. It tells us the relationship between two positions you have in your portfolio or considering acquiring. Over a given time period, the two securities movetogether when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
VALN
+ 0.87
MBOT
VZ
+ 0.81
MBOT
BAC
+ 0.81
MBOT
BAC
+ 0.79
VZ
VZ
+ 0.73
VALN
BAC
+ 0.69
VALN
  
High negative correlations   
CSCO
- 0.64
VALN
KO
- 0.64
ME
CSCO
- 0.6
MBOT
CSCO
- 0.49
BAC
CSCO
- 0.39
MRK
ME
- 0.34
MRK

Risk-Adjusted Indicators

Nowadays, there is a big difference between Pfizer Stock performing well and Pfizer company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Pfizer's multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation		Jensen
Alpha		Sortino
Ratio		Treynor
Ratio		Semi
Deviation		Information
Ratio		Expected
Shortfall		Potential
Upside		Value
At Risk		Maximum
Drawdown
MRK 1.02 (0.08)  0.00 (0.19)  0.00 (0.06)  0.00  1.88 (2.85)  6.97 
MBOT 3.40 (0.54)  0.00 (0.62)  0.00 (0.12)  0.00  7.14 (7.36)  24.20 
ME 3.06  0.04  0.01  0.03  3.68  0.0096 (3.42)  5.94 (6.35)  18.39 
VALN 3.12 (0.38)  0.00 (0.49)  0.00 (0.09)  0.00  5.81 (7.10)  19.68 
VZ 0.92  0.03  0.02  0.06  1.28  0.0241 (0.86)  1.83 (2.15)  5.12 
KO 0.69 (0.03)  0.00 (0.07)  0.00 (0.0322)  0.00  1.54 (1.30)  4.97 
BAC 1.29 (0.17)  0.00 (0.12)  0.00 (0.09)  0.00  2.00 (3.32)  8.39 
CSCO 0.94  0.13  0.11  0.18  1.04  0.10 (0.99)  1.57 (2.13)  7.63 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Pfizer without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Price Exposure Probability Now

   

Price Exposure Probability

Analyze equity upside and downside potential for a given time horizon across multiple markets
All  Next Launch Module

Pfizer Corporate Directors

Pfizer corporate directors refer to members of a Pfizer board of directors. The board of directors generally takes responsibility for the Pfizer's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Pfizer's board members must vote for the resolution. The Pfizer board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Shantanu NarayenLead Independent DirectorProfile
Susan DesmondHellmannIndependent DirectorProfile
Stephen SangerIndependent DirectorProfile
James QuinceyIndependent DirectorProfile

Already Invested in Pfizer Inc?

The danger of trading Pfizer Inc is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Pfizer is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Pfizer. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Pfizer Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Your Equity Center. For information on how to trade Pfizer Stock refer to our How to Trade Pfizer Stock guide. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for Pfizer Stock analysis

When running Pfizer Inc price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.471
Dividend Share
1.6
Earnings Share
5.47
Revenue Per Share
17.891
Quarterly Revenue Growth
0.019
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine Pfizer value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2023 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY